Ultime notizie per DocGo (NASDAQ:DCGO) Azioni

DocGo

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.

DocGo Inc

Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) lowers FY2024 sales outlook from $495.00 million-505.00 million to $487.00 million-495.00 million.

News

Guidance

NDLS

Noodles Lowers FY2024 Sales Guidance from $495.00M-505.00M to $487.00M-495.00M  VS Est.499M

Personalis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.36) by 77.78 percent. This is a 6.67 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $25.709 million which beat the analyst consensus estimate of $21.324 million by 20.56 percent. This is a 40.89 percent increase over sales of $18.247 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

PSNL

Personalis Q3 2024 GAAP EPS $(0.64) Misses $(0.36) Estimate, Sales $25.709M Beat $21.324M Estimate

Nextdoor Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIND#NYSE">KIND</a>) sees Q4 sales of $63.000 million vs $62.00 million estimate.

KIND

Nextdoor Holdings Sees Q4 Sales $63.000M vs $62.00M Est

2024 EARNINGS GUIDANCE REAFFIRMED
Black Hills reaffirms its guidance issued on Feb. 7, 2024, for 2024 earnings per share available for common stock to be in the range of $3.80 to $4.00, which was based on the following assumptions:
<ul>
<li>Normal weather conditions within our utility service territories including temperatures, precipitation levels and wind conditions;</li>
<li>Normal operations and weather conditions for planned construction, maintenance and/or capital investment projects;</li>
<li>Constructive and timely outcomes of utility regulatory dockets;</li>
<li>No significant unplanned outages at our generating facilities;</li>
<li>Equity issuance of $170 million to $190 million through the at-the-market equity offering program; and</li>
<li>Production tax credits of approximately $18 million associated with wind generation assets.</li>
</ul>
During the first nine months of 2024, Black Hills issued equity within the forecasted range, completed the sale of production tax credits, and mitigated the financial impacts of mild weather and unplanned generation outages.

Black Hills Corp Sees FY24 EPS $3.80-$4.00 Vs $3.92 Est.

Braemar Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHR#NYSE">BHR</a>) reported quarterly AFFO of $(0.24) per share which missed the analyst consensus estimate of $(0.06) by 300 percent. This is a 200 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $148.40 million which missed the analyst consensus estimate of $154.66 million by 4.05 percent. This is a 7.14 percent decrease over sales of $159.80 million the same period last year.

Braemar Hotels & Resorts Q3 2024 AFFO $(0.24) Misses $(0.06) Estimate, Sales $148.40M Miss $154.66M Estimate

BBSI

Barett Business Services Sees FY24 Gross Billings Growth 7%-8%.

AppLovin Sees Q4 2024 Revenue $1.24B-$1.26B; Sees Adj. EBITDA $740M-$760M

SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) reported quarterly losses of $(15.33) per share. This is a 2687.27 percent decrease over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $260.903 million which missed the analyst consensus estimate of $269.380 million by 3.15 percent. This is a 64.03 percent decrease over sales of $725.305 million the same period last year.

SEDG

SolarEdge Technologies Q3 2024 Adj. EPS $(15.33) Down From $(0.55) YoY, Sales $260.903M Miss $269.380M Estimate

Regional bank stocks surged on Wednesday, marking their strongest one-day performance in four years as investors bet on a more favorable banking sector environment when Donald Trump returns <a href="https://www.benzinga.com/topic/donald-trump">to the White House.</a>
The SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) — which tracks a basket of 147 small- and mid-cap U.S. banks — jumped 13.4%, posting its largest rally since November 2020. Back then, the announcement of the first COVID-19 vaccine sparked a broad market rebound.
In Wednesday's trading, regional banks outshined even the biggest U.S. banks. Financials were the top-performing sector in the S&amp;P 500, with the Financials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) rising 6%. 
Yet regional banks saw an even greater lift, driven by expectations that Trump&#8217;s policies will uniquely benefit smaller, domestic-focused institutions.
The strength in regional banks also fueled a broader rally in small-cap stocks. The Russell 2000 index, which includes a significant portion of regional banks, surged 6% as investor optimism spread across smaller, U.S.-centric companies.
Regional banks are the most representative sector of the Russell 2000 index, which soared by 6% on Wednesday. 
<h4 class="wp-block-heading">Chart: Regional Banks Mark Best Day Since Covid-19 Vaccine Announcement </h4>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65-1024x501.png" alt="" class="wp-image-633735" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65-1024x501.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65-768x376.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65-1536x752.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160718/image-65.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">JPMorgan&#8217;s Elian Identifies 7 Tailwinds For Regional Banks</h3>
JPMorgan analyst Anthony Elian sees multiple factors that could fuel a strong performance for regional banks under Trump&#8217;s leadership.
&#8220;We view these results as being favorable for the regional bank sector tied to several tailwinds,&#8221; Elian wrote in a note on Wednesday. 
He highlighted seven main drivers:
<ol>
<li>Increased lending activity – A pro-business and onshoring agenda is expected to boost lending, potentially driving a revival in loan growth across the industry.</li>
<li>Lower corporate taxes – Trump&#8217;s anticipated tax cuts could enhance profitability for regional banks by reducing their tax burden.</li>
<li>Eased regulatory environment – According to Elian, &#8220;a second Trump administration would include an easier backdrop for regulation for the industry,&#8221; which could help banks reduce compliance costs and expand operations.</li>
<li>Uptick in M&amp;A activity – With a favorable regulatory climate, the sector could see an increase in mergers and acquisitions, a trend that was prevalent during Trump's first term and could benefit mid-sized banks seeking growth.</li>
<li>Attractive valuations – Elian noted that regional banks remain undervalued by historical standards, suggesting &#8220;there is still material upside on the table.&#8221;</li>
<li>Steep Treasury yield curve, Fed still in easing mode – With the Treasury yield curve in a steep pattern and the Federal Reserve to keep lowering rates, regional banks could benefit from improved net interest margins (NIMs) and net interest income (NII), boosting their earnings and profitability over time.</li>
<li>Underweight positioning – Elian highlighted that investors are still largely underweight on regional bank stocks, indicating room for increased demand as sentiment shifts.</li>
</ol>
JPMorgan&#8217;s Elian identified a few standout names in the regional banking space. Among his top picks are First Citizens BancShares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) and Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), both of which are well-positioned to take advantage of the expected uptrend in the sector.
<h3 class="wp-block-heading">Trump&#8217;s 2016 Win Offers Historical Context For Sector Rally</h3>
The market's optimism is further bolstered by historical precedent. Regional bank stocks were among the biggest early beneficiaries following Trump's 2016 election victory.
Between Nov. 9, 2016, and Jan. 10, 2017, the KRE ETF surged nearly 20%, significantly outperforming other sectors during that period.
<h4 class="wp-block-heading">Chart: Performance Of Regional Bank ETF (Nov. 9, 2016 &#8211; Jan. 10, 2017) </h4>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64-1024x501.png" alt="" class="wp-image-633728" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64-1024x501.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64-768x376.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64-1536x752.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06160352/image-64.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41783357/how-did-s-p-500-sectors-perform-during-trumps-first-term-could-this-time-be-different">How Did S&amp;P 500 Sectors Perform During Trump&#8217;s First Term? Could This Time Be Different?</a></li>
</ul>
Image: Midjourney

Sector ETFs

Politics

Markets

Movers

FCNCA

Regional Bank Stocks Notch Strongest Day In 4 Years: Why Analysts Expect 'Several Tailwinds' From Trump Policies

2024 Financial Outlook
Certara is updating its 2024 outlook, and expects the following:
<ul>
<li>Full year 2024 revenue to be in the range of $380 million to $385 million.</li>
<li>Full year adjusted EBITDA to be in the range of $120 million to $124 million.</li>
<li>Full year adjusted diluted earnings per share is expected to be in the range of $0.41 - $0.44.</li>
<li>Fully diluted shares are expected to be in the range of 160 million to 162 million.</li>
</ul>

CERT

Certara Sees FY24 EPS $0.41-$0.44 Vs $0.41 Est.; Revenue $380M-$385M Vs $386.5M Est.

AMC Enter Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. The company reported quarterly sales of $1.35 billion which beat the analyst consensus estimate of $1.33 billion by 1.05 percent. This is a 4.12 percent decrease over sales of $1.41 billion the same period last year.

AMC Enter Hldgs Q3 2024 Adj EPS $(0.04) Beats $(0.11) Estimate, Sales $1.35B Beat $1.33B Estimate

Barrett Bus Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBSI#NASDAQ">BBSI</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.69 by 7.25 percent. The company reported quarterly sales of $294.278 million which beat the analyst consensus estimate of $287.279 million by 2.44 percent. This is a 7.66 percent increase over sales of $273.328 million the same period last year.

Barrett Bus Servs Q3 2024 GAAP EPS $0.74 Beats $0.69 Estimate, Sales $294.278M Beat $287.279M Estimate

Reaffirming Fiscal Year 2025 Outlook
Kyndryl is reaffirming its outlook for its fiscal year 2025, which runs from April 2024 to March 2025:
<ul>
<li>Adjusted EBITDA margin of at least 16.3%, representing a year-over-year increase of at least 160 basis points.</li>
<li>Adjusted pretax income of at least $460 million, representing a year-over-year increase of at least $295 million.</li>
<li>Constant-currency revenue growth of (2%) to (4%), which now implies fiscal 2025 revenue of $15.2 to $15.5 billion based on recent exchange rates. The Company continues to expect to deliver year-over-year constant-currency revenue growth in the fourth quarter of the fiscal year.</li>
<li>Adjusted free cash flow of approximately $300 million.</li>
</ul>
Forecasted amounts are based on currency exchange rates as of October 2024.

Kyndryl Reaffirming FY25 Revenue Growth Outlook Of (2%) To (4%), Which Now Implies Fiscal 2025 Revenue Of $15.2B-$15.5B Vs $15.27B Est.

EnerSys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENS#NYSE">ENS</a>) reported quarterly earnings of $2.05 per share which missed the analyst consensus estimate of $2.07 by 0.97 percent. The company reported quarterly sales of $883.700 million which missed the analyst consensus estimate of $887.696 million by 0.45 percent. This is a 1.92 percent decrease over sales of $901.000 million the same period last year.

EnerSys Q2 2025 Adj. EPS $2.05 Misses $2.07 Estimate, Sales $883.700M Miss $887.696M Estimate

Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.61 by 21.31 percent. This is a 362.5 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $1.35 billion which beat the analyst consensus estimate of $1.31 billion by 2.72 percent. This is a 28.02 percent increase over sales of $1.05 billion the same period last year.

COHR

Coherent Q1 2025 Adj EPS $0.74 Beats $0.61 Estimate, Sales $1.35B Beat $1.31B Estimate

Crane NXT Narrows FY24 Adj. EPS From $4.10-$4.35 To $4.22-$4.30 Vs $4.26 Est; Sees Sales Growth 6%-8%

Tanger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) raises FY2024 FFO guidance from $2.05-2.12 to $2.09-2.13 vs $2.09 analyst estimate..

Tanger Raises FY2024 FFO Guidance from $2.05-2.12 to $2.09-2.13 vs $2.09 Est

Guardant Health Raises FY24 Revenue From $690M-$700M To $720M-$725M Vs $695.221M Est.

ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.77 by 41.56 percent. This is a 68.75 percent decrease over earnings of $1.44 per share from the same period last year. The company reported quarterly sales of $702.04 million which missed the analyst consensus estimate of $714.92 million by 1.80 percent. This is a 2.20 percent increase over sales of $686.92 million the same period last year.

MODV

ModivCare Q3 Adj $0.45 Misses $0.77 Estimate, Sales $702.04M Miss $714.92M Estimate

2024 Financial Guidance
The company now expects 2024 Adjusted EBITDA between $7 billion and $7.150 billion, which is an increase to the midpoint of guidance by $125 million. In addition, the company continues to expect 2024 growth capex between $1.45 billion and $1.75 billion and maintenance capex between $1.1 billion and $1.3 billion, which includes capital of $350 million for emissions reduction and modernization initiatives. For 2025, the company continues to expect Adjusted EBITDA between $7.2 billion and $7.6 billion with growth capex between $1.65 billion and $1.95 billion and maintenance capex between $750 million and $850 million, which includes capital of $100 million for emissions reduction and modernization initiatives. Williams anticipates a leverage ratio midpoint for 2024 of 3.80x and an increase in the dividend by 6.1% on an annualized basis to $1.90 in 2024 from $1.79 in 2023.

Williams Sees FY24 Adj. EBITDA $7B-$7.15B

DocGo Inc. (DCGO) Q2 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Curaleaf Holdings (CURLF – Research Report) and DocG...

Analysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and DocGo (DCGO)

Canaccord Genuity analyst Richard Close has maintained their bullish stance on DCGO stock, giving a Buy rating today. Richard Close has given his B...

Buy Rating Affirmed for DocGo on Strong Quarterly Performance and Positive Growth Trajectory

DocGo (DCGO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on August 7. Analyst Pito Chickering from Deu...

DocGo: A Strong Buy on Robust Financial Performance and Growth Prospects

Northland Securities analyst Michael Latimore maintained a Buy rating on DocGo (DCGO – Research Report) today and set a price target of $8.00. The ...

Northland Securities Sticks to Its Buy Rating for DocGo (DCGO)

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 Best Stocks to Buy Now, 8/26/2024, According to Top Analysts

The latest announcement is out from DocGo ( ($DCGO) ). DocGo Inc. has announced the appointment of Dr. Stephen K. Klasko as the new Chair of its Bo...

DocGo Appoints Dr. Stephen Klasko as New Board Chair

DocGo appoints Stephen Klasko as chair

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on DocGo (DCGO – Research Report), Avidity Biosciences ...

Analysts' Top Healthcare Picks: DocGo (DCGO), Avidity Biosciences (RNA)

Ambulnz by DocGo and Bayhealth renew partnership, extending contract for three years

CURLF

DCGO

OPRA

RARE

Press Releases

DocGo Launches Mobile X-Ray Program in Partnership with MinXray

DocGo Announces Strong Second Quarter 2024 Results

DocGo Announces Participation at Four Upcoming Investor Conferences

DocGo Expands Care Gap Closure Program to Enhance Healthcare Access for Hundreds of Thousands of Medicaid Recipients in California

DocGo Named Finalist for National Compliance Awards

DocGo Appoints Eiwe Lingefors as New Chief Information Officer

DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years

DocGo to Announce Third Quarter 2024 Results on Thursday, November 7, 2024

Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm

Accolade

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Biodesix

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

23andMe Holding

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

OPKO Health

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Pennant Gr

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

SBC Medical Group Holdings Incorporated - Common Stock

SBC Medical Group Holding

SHL Telemedicine Ltd - American Depositary Shares

Comments

DocGo

Notizie

Ultime notizie per DocGo (NASDAQ:DCGO) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO